0000914190-12-000516.txt : 20120823 0000914190-12-000516.hdr.sgml : 20120823 20120823174825 ACCESSION NUMBER: 0000914190-12-000516 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120821 FILED AS OF DATE: 20120823 DATE AS OF CHANGE: 20120823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koehn Paul A CENTRAL INDEX KEY: 0001428164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 121052880 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2012-08-21 0001180145 Cardiovascular Systems Inc CSII 0001428164 Koehn Paul A 651 CAMPUS DRIVE ST. PAUL MN 55112 0 1 0 0 VP Quality & Operations Common Stock 2012-08-21 4 S 0 1387 9.1909 D 68759 D Common Stock 2012-08-22 4 S 0 235 9.0245 D 68524 D Common Stock 2012-08-23 4 S 0 874 8.8973 D 67650 D Stock Option (right to buy) 8.83 2017-04-17 Common Stock 35585 35585 D Stock Option (right to buy) 8.83 2017-04-17 Common Stock 1294 1294 D Stock Option (right to buy) 7.90 2017-06-11 Common Stock 8087 8087 D Stock Option (right to buy) 7.90 2017-10-08 Common Stock 12940 12940 D Stock Option (right to buy) 12.15 2017-12-11 Common Stock 32350 32350 D Stock Option (right to buy) 8.75 2019-03-01 Common Stock 8087 8087 D Warrant 8.83 2009-02-25 2014-02-24 Common Stock 940 940 D In connection with the vesting and delivery of restricted stock, and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2012, on each date shares were sold and the net proceeds were used to pay required withholding taxes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.39 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.08 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.74 to $8.99 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully exerciseable. /s/ Scott J. Dorfman as Attorney-in-Fact for Paul Koehn pursuant to Power of Attorney previously filed. 2012-08-23